LABANCA, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 76
EU - Europa 55
AS - Asia 51
SA - Sud America 11
AF - Africa 1
Totale 194
Nazione #
US - Stati Uniti d'America 75
SG - Singapore 30
IT - Italia 20
DE - Germania 15
BR - Brasile 11
FI - Finlandia 8
IN - India 7
CN - Cina 5
GB - Regno Unito 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
NL - Olanda 3
TR - Turchia 2
BD - Bangladesh 1
CA - Canada 1
FR - Francia 1
IR - Iran 1
JP - Giappone 1
PK - Pakistan 1
SE - Svezia 1
TN - Tunisia 1
Totale 194
Città #
Singapore 20
Munich 14
Dallas 12
Chandler 11
Ashburn 8
Chicago 8
Turku 6
Bengaluru 5
Hefei 5
Santa Clara 5
The Dalles 5
London 4
Hong Kong 3
Olomouc 3
Paola 3
Delhi 2
Gesuiti 2
Helsinki 2
Los Angeles 2
Amsterdam 1
Ankara 1
Atlanta 1
Baependi 1
Baturité 1
Bay City 1
Boardman 1
Bom Despacho 1
Bragança Paulista 1
Florianópolis 1
Indian Trail 1
Lahore 1
Landshut 1
Lawrence 1
Limeira 1
Menzel Temime 1
Minneapolis 1
Pesqueira 1
Pittsburgh 1
Princeton 1
Santo André 1
Squillace 1
Stockholm 1
Taubaté 1
Tokyo 1
Vitória de Santo Antão 1
Votuporanga 1
Totale 147
Nome #
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 75
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 52
Belantamab mafodotin in multiple myeloma 35
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 25
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 14
Totale 201
Categoria #
all - tutte 1.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 9 5 0 0
2022/202325 2 1 1 1 4 5 0 3 2 3 3 0
2023/202426 5 5 2 0 1 6 0 0 0 1 4 2
2024/202591 3 2 1 3 5 9 2 2 6 1 30 27
2025/202645 13 14 13 5 0 0 0 0 0 0 0 0
Totale 201